This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kaneko, K.
Right arrow Articles by Inoue, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kaneko, K.
Right arrow Articles by Inoue, M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2005, p. 2955-2958, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2955-2958.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Gene Mutations Responsible for Overexpression of AmpC ß-Lactamase in Some Clinical Isolates of Enterobacter cloacae

Kenichi Kaneko,1 Ryoichi Okamoto,1,2 Ryuichi Nakano,1 Sayoko Kawakami,3 and Matsuhisa Inoue1,2*

Department of Environmental Infectious Diseases, Graduate School of Medical Sciences,1 Department of Microbiology, School of Medicine, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa,2 Department of Central Laboratory, School of Medicine, Teikyo University, 2-11-1, Kaga, Itabashi-ku, Tokyo, Japan3

Received 28 October 2004/ Returned for modification 12 December 2004/ Accepted 20 February 2005

AmpC regulatory genes in 21 ceftazidime-resistant clinical isolates of Enterobacter cloacae (MICs of ≥16 µg/ml) were characterized. All isolates exhibited AmpC overproduction due to AmpD mutation. Additionally, we found two AmpR mutants among the isolates. This is the first report of chromosomal ampR mutation in clinical isolates of E. cloacae.


* Corresponding author. Mailing address: Department of Environmental Infectious Diseases, Graduate School of Medical Sciences, Kitasato University, 1-15-1 Kitasato, Sagamihara, Kanagawa 228-8555, Japan. Phone: 81-42-778-9349. Fax: 81-42-778-9350. E-mail: matsu{at}kitasato-u.ac.jp.


Journal of Clinical Microbiology, June 2005, p. 2955-2958, Vol. 43, No. 6
0095-1137/05/$08.00+0     doi:10.1128/JCM.43.6.2955-2958.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Asgarali, A., Stubbs, K. A., Oliver, A., Vocadlo, D. J., Mark, B. L. (2009). Inactivation of the Glycoside Hydrolase NagZ Attenuates Antipseudomonal {beta}-Lactam Resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53: 2274-2282 [Abstract] [Full Text]  
  • Jacoby, G. A. (2009). AmpC {beta}-Lactamases. Clin. Microbiol. Rev. 22: 161-182 [Abstract] [Full Text]  
  • Manzur, A., Tubau, F., Pujol, M., Calatayud, L., Dominguez, M. A., Pena, C., Sora, M., Gudiol, F., Ariza, J. (2007). Nosocomial Outbreak Due to Extended-Spectrum-Beta-Lactamase- Producing Enterobacter cloacae in a Cardiothoracic Intensive Care Unit. J. Clin. Microbiol. 45: 2365-2369 [Abstract] [Full Text]  
  • Gonzalez-Lopez, J. J., Sabate, M., Lavilla, S., Larrosa, M. N., Bartolome, R. M., Prats, G. (2006). In Vivo Reversion to the Wild-Type {beta}-Lactam Resistance Phenotype Mediated by a Plasmid Carrying ampR and qnrA1 in Enterobacter cloacae.. Antimicrob. Agents Chemother. 50: 3175-3178 [Abstract] [Full Text]  
  • Schmidtke, A. J., Hanson, N. D. (2006). Model System To Evaluate the Effect of ampD Mutations on AmpC-Mediated {beta}-Lactam Resistance.. Antimicrob. Agents Chemother. 50: 2030-2037 [Abstract] [Full Text]  
  • Kaneko, K., Sato, Y., Tokunaga, S.-k., Tamaki, S.-k., Okamoto, R., Inoue, M. (2006). AmpC {beta}-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers. J Antimicrob Chemother 57: 369-371 [Full Text]